Liquid Biopsies in Colorectal Cancer: Monitoring Genetic Heterogeneity

Kolch, 2015, The dynamic control of signal transduction networks in cancer cells, Nat. Rev. Cancer, 15, 515, 10.1038/nrc3983

Guinney, 2015, The consensus molecular subtypes of colorectal cancer, Nat. Med., 21, 1350, 10.1038/nm.3967

Isella, 2015, Stromal contribution to the colorectal cancer transcriptome, Nat. Genet., 47, 312, 10.1038/ng.3224

Ahronian, 2015, Clinical acquired resistance to RAF inhibitor combinations in BRAF-mutant colorectal cancer through MAPK pathway alterations, Cancer Discov., 5, 358, 10.1158/2159-8290.CD-14-1518

Llosa, 2015, The vigorous immune microenvironment of microsatellite instable colorectal cancer is balanced by multiple counter-inhibitory checkpoints, Cancer Discov., 5, 43, 10.1158/2159-8290.CD-14-0863

Le, 2015, PD-1 blockade in tumors with mismatch-repair deficiency, N. Engl. J. Med., 372, 2509, 10.1056/NEJMoa1500596

Pietrantonio, 2016, Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer, Clin. Cancer Res.

Bettegowda, 2014, Detection of circulating tumor DNA in early- and late-stage human malignancies, Sci. Transl. Med., 6, 224ra224, 10.1126/scitranslmed.3007094

Van Emburgh, 2016, Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer, Nat. Commun., 8, 13665, 10.1038/ncomms13665

Siravegna, 2015, Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients, Nat. Med., 21, 795, 10.1038/nm.3870

Tsai, 2016, Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients, Sci. Rep., 6, 24517, 10.1038/srep24517

Alix-Panabières, 2016, Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy, Cancer Discov., 6, 479, 10.1158/2159-8290.CD-15-1483